SOFIE Biosciences doses first patient in Phase III FAPI-PRO trial for pancreatic cancer imaging
SOFIE Biosciences has dosed the first patient in its Phase III FAPI-PRO trial evaluating 18F-FAPI-74 PET/CT for detecting metastatic pancreatic ductal adenocarcinoma, with 18 sites planned across 24 months.
Radiopharmaceutical | 13/02/2026 | By News Bureau
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of USD 250 Million
The addition of Evergreen’s scalable manufacturing capabilities and infrastructure enhances Lantheus’ ability to meet the complex demands of radiopharmaceutical development and production.
Radiopharmaceutical | 29/01/2025 | By Aishwarya | 338
Telix Pharmaceuticals Completes Acquisition of ARTMS
Telix Pharmaceuticals Ltd. has completed the acquisition of ARTMS Inc.
<br />
Radiopharmaceutical | 12/04/2024 | By Aishwarya | 600
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy